Qifan Zhu

Qifan Zhu is a Senior Scientist at Bristol Myers Squibb, starting in October 2023, focusing on in vivo pharmacology for Discovery Immunology. Prior to this role, Qifan Zhu served at AbbVie from December 2018 to September 2023 as a Senior Scientist II, overseeing biologics and small molecule pipeline programs for inflammatory indications, and leading collaborations on GPCR small molecule programs. Contributions included proposing and validating new therapeutic targets and serving on the Gastrointestinal Discovery Disease Team. Earlier experience includes a position as Senior Scientist I at AbbVie, where Qifan Zhu performed early target validation and validated a colitis model. Qifan Zhu's academic background includes a Ph.D. in Immunology from The University of Tennessee Health Science Center and a BS in Bioscience from Huazhong University of Science and Technology, with doctoral studies conducted at St. Jude Children's Research Hospital from 2013 to 2018.